(Alliance News) - The following is a round-up of earnings and trading updates by London-listed companies, issued on Tuesday and not separately reported by Alliance News: Read More
(Alliance News) - Jubilee Metals Group PLC reported on Tuesday its interim loss narrowed at it prepared to ramp up copper production after disposing of chrome and platinum group metal operations. Read More
(Alliance News) - Edinburgh Worldwide Investment Trust PLC on Tuesday responded to an "enhanced liquidity proposal" from activist investor Saba Capital Management LP. Read More
Optima Health PLC - Sheffield, England-based occupational health services provider - Launches open offer to raise up to GBP35.0 million before expenses through the issue of up to 20.0 million shares at 175 pence each. Says it will use net proceeds to repay the GBP30.0 million bridge facility used to partially finance its acquisition of PAM Healthcare Ltd, completed last week. The bridge facility was provided by Deacon Street Partners Ltd, which is controlled by substantial shareholder Michael Ashcroft. Qualifying shareholders will be able to subscribe for open offer shares at the issue price, on the basis of one open offer share for every 4.439 existing ordinary shares. Issue price represents a discount of 2.8% to the closing middle market price of 180p on Monday, and around 18% to the closing price of 213p on February 13, the latest practicable date before the PAM acquisition was announced. Read More
(Alliance News) - Vista Parcs Group PLC on Tuesday said that it expects to be admitted and start trading on the AIM in mid-April. Read More
Poolbeg Pharma PLC - London-based clinical stage biopharmaceutical firm focused on cancer immunotherapy - Receives formal notification of the grant for its POLB 001 cancer immunotherapy-induced cytokine release syndrome patent application from the IP Australia patent office. Says the patent covers the use of any p38 MAPK inhibitor, including POLB 001, for the prevention of cancer immunotherapy-induced CRS, supported by Poolbeg's proprietary data. "This represents the first national grant within Poolbeg's cancer immunotherapy-induced CRS patent family, marking an important milestone for the company," Poolbeg says. Adds that the grant further strengthens its "robust intellectual property portfolio, enhancing POLB 001's future value and appeal to potential partners." Read More
(Alliance News) - Peel Hunt Ltd on Tuesday said it expects to deliver full year revenue and profit that are "materially" ahead of market expectations. Read More
(Alliance News) - Unilever PLC on Tuesday confirmed it has agreed to combine its Foods business with McCormick & Company Inc, creating a USD20 billion revenue "global flavour powerhouse" and accelerating its shift to a pureplay home and personal care group. Read More
(Alliance News) - Baillie Gifford Shin Nippon PLC on Tuesday reported a rise in net asset value and increased its dividend, though it continued to underperform its benchmark amid challenges in Japanese small-cap growth stocks. Read More
(Alliance News) - James Halstead PLC on Tuesday raised its dividend despite sales falling back in difficult markets. Read More
(Alliance News) - Secure Trust Bank PLC on Tuesday noted the UK financial watchdog's announcement on motor finance redress. Read More
(Alliance News) - Princes Group PLC on Tuesday reported a swing to annual profit and revenue growth, as it warned it will raise prices by at least 5% to offset rising costs linked to the war in Iran. Read More